Pricing Log in Create free account
Friday 6 November 2026 Export ZBH’s income statement to Excel — free account

Zimmer Biomet Holdings, Inc.

ZBH Healthcare Medical Devices

Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024.

Revenue
+3.07%
EPS
−13.5%
Free cash flow
+29.8%
Total debt
−7.50%

Quarter to September 2026, against a year earlier

106.56 0.29 −0.27%
Market cap
$20.4B
P/E
26.9×
Fwd P/E
18.9×
Dividend yield
0.90%
F-score
6/9
Altman Z
2.38
Beneish M
−2.59
Dividend safety
72/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Zimmer Biomet Holdings, Inc. (ZBH) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a price to free cash flow of 18.2×. Over the past ten years it has ranged from 14.7× (December 2018) to 119× (April 2021); the current reading is higher than 15% of that period. That is below the Medical Devices industry median of 28.8× and below the Healthcare sector median of 21.1×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 16.5× (39.70%)
FY2024 27.4× (5.29%)
FY2023 28.9× (5.42%)
FY2022 30.6× 15.15%
FY2021 26.6× (56.97%)
FY2020 61.8× 66.28%
FY2019 37.1× 134.67%
FY2018 15.8× (29.84%)
FY2017 22.6× 22.62%
FY2016 18.4× (59.03%)

Quarterly newest first

Period Price to free cash flow Change
Sep 2026 15.2× (5.03%)
Jun 2026 16.0× (8.73%)
Mar 2026 17.5× 5.83%
Dec 2025 16.5× (14.35%)
43 more quarters

Against its own ten years

Low 14.7× High 119×
Ten-year median 26.3×
Current reading's percentile 15

Price to free cash flow against peers

Company Price to free cash flow
SNN Smith & Nephew SNATS, Inc. compare 7.1×
PHG Koninklijke Philips N.V. compare 14.1×
GMED Globus Medical, Inc. compare 14.5×
ZBH Zimmer Biomet Holdings, Inc. 18.2×
STE STERIS plc compare 26.4×
DXCM DexCom, Inc. compare 28.8×
PODD Insulet Corporation compare 46.4×
PEN Penumbra, Inc. compare 63.1×
GKOS Glaukos Corporation compare 360×
Medical Devices industry median 28.8×
Healthcare sector median 21.1×
Market median 14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on ZBH